Skip to content

A Study to Evaluate the Safety and Efficacy of Jingjie Diffractive Optical Element (DOE) Lenses in Slowing Axial Elongation in Pediatric Myopia

A Study to Evaluate the Safety and Efficacy of Jingjie Diffractive Optical Element (DOE) Lenses in Slowing Axial Elongation in Pediatric Myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116515
Enrollment
Unknown
Registered
2026-01-12
Start date
2026-01-17
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Test group :Wearing Jingvision Diffractive Optical Lenses (DOE)

Sponsors

Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=6 years and = -6.00 D, with astigmatism =5.0 4. The child must be accompanied by a parent or guardian who is able to read and understand the content of the informed consent form and voluntarily sign the informed consent form together with the child

Exclusion criteria

Exclusion criteria: 1. History of ocular trauma or intraocular surgery that may affect the wearing of spectacles. 2. Intraocular pressure >21 mmHg, or an interocular difference in intraocular pressure >5 mmHg. 3. Concurrent other ocular diseases, such as various inflammatory conditions (e.g., uveitis), glaucoma, cataract, fundus diseases, ocular tumors, ocular trauma, patients with manifest strabismus; and any other ocular pathologies that may affect visual function. 4. Patients with systemic diseases leading to compromised immunity (e.g., diabetes, Down syndrome, rheumatoid arthritis, psychiatric disorders, or any other conditions deemed by the investigator as unsuitable for spectacle wear). 5. Use of any myopia control products within the past three months, such as orthokeratology lenses, multifocal contact lenses, specially designed myopia control spectacle lenses (e.g., progressive addition lenses), low-concentration atropine, red light therapy devices, etc. (This does not include mydriatic agents used for refractive examinations). 6. Only one eye meets the inclusion criteria. 7. Inability to adhere to the ocular follow-up examinations as required by the study protocol. 8. Other conditions considered by the investigator as grounds for exclusion.

Design outcomes

Primary

MeasureTime frame
Axial length change;lens wear duration;

Secondary

MeasureTime frame
diopter (spherical power, astigmatism);corneal curvature;choroidal thickness and blood flow;

Countries

China

Contacts

Public ContactLu Yiqiu

Eye Hospital, WMU

luyiqiu@eye.ac.cn+86 159 9073 6066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026